Bath & Body Works stock rose slightly after reporting Q4 results. JPMorgan and Telsey maintain buy ratings with price targets of $47 and $43, respectively

Key Takeaways Bath & Body Works warned that tariffs on Chinese goods would negatively affect its full-year results.CEO Gina Boswell also noted that the retail industry faced "complex challenges."The company's guidance offset better-than-expected fourth-quarter profit and sales.

Shares of Bath & Body Works fell 12% on Thursday after the company forecast annual sales and profit largely below expectations as the fragrances and scented candles maker grapples with uncertain discretionary spending.